HormoneFDA Approved

Oxytocin

A peptide hormone used in FDA-approved medical settings but also frequently reframed in wellness and research-market discussions.

HormoneFDA ApprovedPeptide Hormone

Also referenced as: Pitocin

Price compare
77 tracked offers across 77 vendors · 14 dosages
Best trust-adjusted value: Peptuvia · Strong trust · $0.83/mg
From
$0.83/mg
Tracked market history

What has the price actually done?

Daily, exact-comparability offers. Discounts use the terms known on each historical date.

-69.3%vs. Aug 10
Current low$0.83/mg
Market median$7.90/mg
Current coverage35 vendors
Observed window90 daily points
How this history is calculated

Effective price per mg uses an active dated override first, then the row-level historical discount, then the vendor default from the same Git revision. Aggregate chart points include exact-comparability offers only. Missing observations remain gaps; the series does not interpolate across unavailable offers or absent snapshots.

Price watch · beta

Let the market come to you.

Watch the best market price or one vendor. Get one email when Oxytocin crosses your target, drops, or sets a new tracked low—without daily noise.

Requires a confirmed Weekly Peptide Intel address, then a separate alert confirmation. Already watching? Manage price alerts. Public prices can change; confirm the final cart total.
Public product evidence72 certificate records mentioning this compound or product name39 provider-linked · 54 exact product matches
Status
FDA Approved

This peptide maps to at least one regulated medical product or label context in the United States.

Research area
Hormone signaling research

This profile is grouped by its dominant research area, not by vendor shelf placement.

Aliases
1

Pitocin

Signal depth
High

FDA label signal · 1397 trials · 29402 PubMed results

Established

Oxytocin is an FDA-approved medicine with substantial published trial evidence. Note that research-market products sold under this name are not the approved medicine and are not held to the same manufacturing or labeling standards.

Oxytocin has 42 name-matched clinical trials (3 international) (highest phase: Phase 4) and 29402 PubMed-indexed publications and holds an FDA drug label. 10 trials have posted results.

🌍 3 international trialsFAERS (approved drug): 2,735
Human data
Approved drug
Trial quality
Large RCT
Outcomes
Surrogate / early
Replication
Meta-analysis
Literature
Top-tier journals

Re-checked nightly against the registries — tracked since 2026-07-09. No band changes yet.

Grades evidence strength, not efficacy or safety. Research-use context; not medical advice. Graded 2026-09-08 from PubMed, ClinicalTrials.gov, ISRCTN, openFDA, Health Canada, and OpenAlex — computed deterministically and refreshed nightly, with a retraction check. How we grade →


What oxytocin is

Oxytocin is a naturally occurring peptide hormone with established medical use in regulated clinical settings. It is also one of the few hormone peptides that people may recognize outside peptide-market culture.

Why it matters

It anchors the hormone category with a peptide that has legitimate clinical history rather than only research-market visibility.

Regulatory context

Oxytocin is associated with FDA-approved medical products and clinical use. That does not make every non-medical or retail framing of oxytocin equivalent to an approved use case.

Practical reading note

This is another case where the ingredient name alone is not enough. Formulation, indication, and clinical context matter.